mit Krediten??und schon wieder sone fragwürdige Batterie,für die es nur nen Abnehmer in China gibt...ich vermute eigentlich,dass du sie schon vorher gekauft hast und heute verkauft hast,denn nachbörslich lief da ja nix .Und wieso erwähnst du den Report von heute nicht???http://www.pinksheets.com/quote/news.jsp?symbol=VLNC daraus:
$2.1 million available under a loan agreement with Berg & Berg and $25.0 million
available under an equity line of credit financing commitment with Berg & Berg. Currently, the Company does not have material sales. Consequently, the Company is dependent on Berg & Berg's continued willingness to fund its continued operations. Under the equity line of financing commitment Berg & Berg has the contractual right to reduce the remaining availability under the line from $25 million to $8.5 million. Further, the commitment expires on March 31, 2004 and Company's right to draw down on the line is limited to $5 million per quarter and is further dependent upon meeting certain operating conditions.
Assuming Berg & Berg continues to fund the operations of the Company at the rate of $5 million per quarter, the Company expects to have sufficient financing through the next twelve months to meet its working capital, capital expenditure and investment requirements. However, if Berg & Berg were to exercise its right to reduce the amounts under the equity line of credit to $8.5 million or if the Company were not able to satisfy the conditions to funding under that line in the first quarter of fiscal 2004, the Company would exhaust its existing sources of liquidity. In such a case, the Company's ability to continue its operations would be dependent on arranging for additional equity or debt financing, which, given the current equity and debt markets, could be difficult to arrange.
3. FINANCING:
On April 9, 2002, the Company sold 6.122 million shares in a new issuance of common stock to a select group of institutional investors, at a price of $2.70 per share. A.G. Edwards & Sons, Inc. and Wm Smith Securities, Incorporated served as placement agents for the offering. The Company raised net proceeds of approximately $15.2 million in the transaction. Proceeds from the financing were used for working capital purposes.
On September 30, 2002, the Company drew down $5.0 million from its equity line of credit financing commitment from Berg & Berg and issued approximately 9.5 million shares of the Company's common stock (See Note 2, Liquidity and Capital Resources).
In October 2001, the Company entered into a loan agreement ("2001 Loan") with Berg & Berg. Under the terms of the agreement, Berg & Berg agreed to advance the Company funds of up to $20 million between the date of the agreement and September 30, 2003. Interest on the 2001 Loan accrues at 8.0% per annum!!!, payable from time to time, and all outstanding amounts with respect to the loans are due and payable on September 30, 2005. As of September 30, 2002, a total of $19,036,000 had been drawn on the 2001 Loan. On June 21, 2002, Berg & Berg agreed to reduce the principal amount of the 2001 loan by $1,106,705,
On November 8, 2002 the Company and Berg & Berg amended an affirmative covenant in the agreement to acknowledge the Nasdaq SmallCap Market as an acceptable market for the listing of the Company's Common Stock. Borrowings on the 2001 Loan, net of the repayment, as of September 30, 2002, were $17,929,000. In conjunction with the 2001 Loan, Berg & Berg received a warrant to purchase 1,402,743 shares of the Company's common stock at the price of $3.208 per share. The warrants were exercisable beginning on the date they were issued and expire on August 30, 2005. The fair value assigned to these warrants, totaling approximately $2,768,000, has been reflected as additional consideration for the debt financing, recorded as a discount on the debt and accreted as interest expense, amortized over the life of the loan.
Founded in 1989, our business has been driven primarily by our research and development efforts, which have fostered our intellectual property position, currently consisting of 722 issued and pending patents, including 254 patents issued in the United States. Since our inception, we have been focused on acquiring and developing our technology, developing our manufacturing capabilities, recruiting personnel, establishing our sales channels and pipeline and acquiring capital.
We introduced the N-Charge(TM) Power System, our first end-user product in February 2002. We must develop reliable sales channels for distribution of our N-Charge(TM) product and any future end-user products. If our N-Charge(TM) product is not commercially accepted, our results of operations will be adversely affected. In addition, failure to develop effective sales channels will significantly impact our future revenue and profitability.
OUR FAILURE TO DEVELOP PARTNERSHIPS WITH OTHER BATTERY MANUFACTURERS WILL LIMIT OUR ABILITY TO WIDELY INTRODUCE OUR PHOSPHATE CHEMISTRY TECHNOLOGY INTO THE MARKETPLACE AND COULD SIGNIFICANTLY IMPACT OUR SALES AND PROFITABILITY IN FUTURE PERIODS.
The Company reported a net loss of $9.6 million, or $0.19 per basic and diluted share, on revenue of $260,000 for the second quarter of fiscal year 2003. These results compare to a net loss of $9.7 million, or $0.19 per basic and diluted share, on revenue of $509,000 in the first quarter of fiscal 2003, and a net loss of $10.1 million, or $0.22 per basic and diluted share, on revenue of $527,000 in the quarter ended Sept. 30, 2001.
Afterhours Best Bid: $1.20 Best Ask: $2 Last Sale: $ 1.35
last 5 Trades:
BERG CARL E 9,457,159 ist das die Bezahlung für den 5Millionen-Kredit vom 30.September?
GODEVAIS STEPHA... 200,000
Analysten:CIBC WORLD MARKETS CORP.,... GERARD KLAUER MATTISON & CO.
10, Extreme Overbought, odds definitely favor short trades.
WATCH for possible breakdown below 1.21, no support in area just below. Type: Continuation breakdown from single support. Target: 0.91, -32.6%
www.nasdaq.com
|
Thread abonnieren
